Spirendolol
![]() | |
Nazivi | |
---|---|
IUPAC naziv 4-[3-(tert-Butilamino)-2-hidroksipropoksi]spiro[3H-inden-2,1'-cikloheksan]-1-on | |
Identifikacija | |
| |
3D model (Jmol) |
|
ChemSpider |
|
| |
UNII |
|
SMILES
| |
Svojstva | |
C21H31NO3 | |
Molarna masa | 345,48 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Spirendolol je antagonist beta adrenergičkog receptora.[3]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Mostaghim, R; Maddox, YT; Ramwell, PW (1986). „Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents”. The Journal of Pharmacology and Experimental Therapeutics. 239 (3): 797—801. PMID 2879033.
- п
- р
- у
Adrenergici
|
|
|
Drugi | |||||||
---|---|---|---|---|---|---|---|
|